This investigation was carried out to study the hypoglycemic effects of Chromium picolinate and Magnesium sulfate on streptozotocin induced diabetic rats. Chromium at levels of 8 and 10ug/ml, Magnesium at level 10 and 12mg/ml. Furthermore, mixture of (chromium 8u/ml + Magnesium10mg) and (chromium10u/ml + Magnesium12mg/ml) administered to diabetic rats for six weeks. Blood glucose and, body weight gain of rats were determined. Also, total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), and triglycerides were determined in the serum of the rats. As well as the activities of serum aspartate transaminase (AST) and alanine transaminase (ALT) were determined.
INTRODUCTION
Diabetes mellitus is a chronic disease disorder of glucose Intolerance. It is characterized by high blood glucose level and glucosuria from dysfunction of pancreatic cells and insulin resistance. The defective cells results in lack of total or partial synthesis of insulin. The resistance is caused by cell membrane where glucose is not transported to the cell for oxidation. As glucose is not metabolized. High amount of glucose is circulating in the blood (hyperglycemia).
To keep the normal level of glucose in the blood, the kidney removes the extra sugar from the blood and excretes it in the urine (glycosuria). Because glucose is not utilized by the body cells, the body is under constant impression of hunger and that is why diabetes feels increased appetite (polyphagia) and eats more frequently (Safadar et al., 2006) .
Diabetes mellitus is one of the most common chronic diseases in children and adolescents (Kelly et al., 2006 and Ogden et al., 2002) .
Diabetes mellitus is considered to be a major health problem in the world. The number of diabetics has been increasing at a rate of around 6%per year.
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Determination of blood glucose:
Blood glucose was measured according to the method described by Alles et al., (1999) using blood glucose meter (free style TM).
Determination of serum enzymatic activity:
The activities of aspartate transaminase (AST) and alanine transaminase (ALT) of serum were determined according to the methods described by Reitman and Frankel (1957) on fully automated chemistry analyzer Roche/Hitachi-912 (Roche Diagnostics, Mannheim, Germany) using Roche Diagnostics GmbH kits. The values were expressed as Iu/L serum.
Determination of serum lipids:
Triglycerides, total cholesterol and high density lipoprotein cholesterol (HDL-C) levels were measured by enzymic-colorimetric procedures using commercial available kits. Triglycerides were carried out according to the method of Fossati and Prancipe (1982) . Total cholesterol (TC) and HDL-C were carried out according to the methods of Richmond (1973) . Low-density lipoprotein cholesterol (LDL-C) was calculated as the difference between total and HD-C according to the method of Friedewald et al., (1972) .
Determination of kidneys functions:
Urea was determined by using a commercial kit (Biomed Company, Germany). According to the method described by (Chaney and Marbach, 1962) .
Creatinine concentrations in the plasma were determined using enzymatic colorimetric kit (Biolabo , Maizy, France) according to the method described by (Fabiny and Ertingshausen ,1971) , based on the colorimetric reaction of creatinine with alkaline picrate measured at 490 nm.
Statistical analysis:
Most of the received data were analyzed statistically using the analysis of variance and the means were further tested using the least significant difference test (LSD) as outlined by Steel and Torrie (1980) .
RESULTS AND DISCUSSION

Effect of feeding at different levels of Chromium picolinate and Magnesium sulfate on Final body weight (g) and Change body weight (g) gain in rats:
Data in Table ( 1) indicate that the mean values of initial body weights of all groups at the start of the experiment were approximately the same and ranged from 201.5 to 205.0 g. At the end of experiment (6 weeks), the final weight of the control diabetic rats (G2) was lower than that of the normal control (G1) and all diabetic rats, All diabetic rats gave negative Change body weight ranged from ( -17g to -7 g). These results are in agreement with those reported by Krol et al., (2010) and Tuzcu et al., (2011) . 
Effect of feeding at different levels of Chromium picolinate and Magnesium sulfate on the organs weight and relative organs weight in rats:
Liver, kidney, heart and pancreas of rats fed on basal diet and other treatments, as well, were weight at the end of experimental period (6 weeks) and the ratio of each organ to final body weight of rats was calculated. The results presented in Table ( 2) revealed that all treatments showed no significant changes in the weight of kidney and Pancreas of all experimental rats. On the other hand, the liver of positive control group had the highest liver weight (9.33 gm) and relatively liver weight (5.043) between all groups. This may be due to high blood glucose.
Whereas negative control G1 and G6 had the lowest liver weight and relatively liver weight. This may be referring of negative control and G6 may be due to treatment. Furthermore, , On the other hand, the heart weights of rats fed with basal diet + chromium picolinate (8ug/ml) + magnesium sulfate (10g/l) in drinking water G7 was higher than that of control rats. 
Effect of different levels of Chromium picolinate and Magnesium sulfate on serum lipids in rats:
Although the relationship between lipids abnormalities and diabetes is complex, there is usually a specific lipid abnormality found in diabetes (Rosalyn and Bauman, 1983) . Also, hypertriglyceridemia, hypercholesrolemia and reduced HDL-C levels were commonly seen in diabetes. The abnormal high level of lipids in diabetes is mainly due to the increase in the mobilization of free fatty acids from the peripheral depots, since the insulin inhibits the hormone sensitive lipase but glucagons, catecholamines and other hormones enhance lipolysis. The marked hyperlipidemia that characterizes the diabetic state may therefore be regarded as a consequence of the fat depots (Al-Shamaony et al., 1994) . According to the results given in Table ( 3), it could be concluded that treated diabetic rats had significantly lower serum total cholesterol, low density lipoprotein cholesterol and triglycerides but they had a significantly higher serum high density lipoprotein cholesterol compared to diabetic control rats.
These results were consistent with those reported by (Anderson, 1992; Fox et. al., 2001 and El-Sayed, 2013) . The ratio of TC/HDL-C was significantly higher in case of diabetic control rats than that of other groups. These results may be due to the treatment of diabetic rats with streptozotocin helped to increase of TC/HDL-C ratio. These results are in a harmony with those reported by Katan et al., (1994) they reported that total cholesterol is not as useful a predictor of coronary heart diseases risk as the relative distribution of cholesterol among lipoprotein e.g. TC/HDL-C and LDL-C/HDL-C ratios. The increasing of triglycerides in streptozotocin diabetes rats that observed in this study may be due to lack of insulin, which normally activates the enzyme lipoprotein lipase. (Baur 1995) stated that the TC/HDL-C ratio should be ranged between 4 and 6 and when it increased above 6 is high risk on heart. The TC/HDL-C ratio is important as an indicator of the coronary artery disease. Hypertriglycermia is one of the risk factors in coronary artery disease and diabetes mellitus is always associated with raised triglycerides.
The same table, showed that, supplementation of drinking water with all type of chromium picolinate led to improvement the TC/HDL-C and TC/LDL-C ratios. Chromium picolinate at a level (8 µg/ml and 10 µg/ml) also recorded the best and nearest of TC/HDL-C, TC/LDL-C and LDL-C/HDL-C to the negative control and comparing with other group, the mean value were (1.75 and 1.67), (3.67 and 3.99) and (0.48 and 0.42) respectively. These values were significantly different comparing with that recorded in positive control. Sayed-Ahmed (2002) supports our findings. Each value was an average of five determinations ± standard error. Values followed b the same letter in column are not significantly different at P ≤ 0.05. G1, G2, G3 G4 …..etc as in Table (1) . Normal values in human should be in the range of: Total cholesterol (below 200 mg/dl) HDL-C (above 45 mg/dl) Total triglyceride (50 -250 mg/dl) LDL-C (< 160 mg/dl) (Baur, 1995) Effect of feeding with different levels of chromium picolinate and magnesium sulfate on serum alanine aminotransferase and aspertate aminotransferase activities in rats. Elevated activities of serum transaminase enzymes are a common sing of hepatic dysfunction, and are more frequently observed among people with diabetes than in the general population. Furthermore, diabetic complications such as limited joint mobility, retinopathy and neuropathy are associated with liver enzyme activities, independent of alcohol consumption, body mass index and metabolic control of diabetes (Brownlee, 2001) . Table (4) represents the effect of different levels of Chromium picolinate and Magnesium sulfate on changes in the activities of serum aspertate transaminase and alanine transaminase.
The activities of hepatic markers were significantly elevated in diabetic rats compared with control rats. The treatment of diabetic rats Chromium and Magnesium reversed the above changes in a significant manner compared with untreated diabetic rats. These results are in the same trend of those reported elsewhere. (Naveen and Farhath, 2012) .Several investigators reported increase in aspertate and alanine transaminase in the liver and serum of streptozotocin diabetic rats (Brownlee, 2001) . The changes in levels of serum enzymes are directly related to the changes in metabolism of its involved enzymes. Murugan and Pari (2007) suggested that liver and kidney functions are highly altered in diabetic state. Treatment with Chromium picolinate and Magnesium sulfate reversed these changes in diabetic rats, which indicates that these substrates protect the hepatic and renal function in the diabetic condition. Each value was an average of five determinations ± standard error. Values followed b the same letter in column are not significantly different at P ≤ 0.05. G1, G2, G3 G4 …..etc as in Table (1). Effect of feeding with different levels of Chromium picolinate and Magnesium sulfate on blood glucose in rats. Table (5) illustrated the mean blood glucose level of normal control and diabetic groups through the experimental periods. Blood glucose levels of diabetic groups were markedly higher than the normal control (G1), data dealing with this case that given in the same table clarified that, also different levels of Chromium picolinate and Magnesium sulfate led to cause a significant decreased in blood glucose level of the diabetic groups (G3, G4, G5, G6, G7 and G8), comparing with the diabetic group fed on control diets (G2). Reduction was observed after three week of feeding till the end of experiment periods; also, the reduction was increased with increasing the feeding period. Apparent also from the same table that, rats fed on basal diet + chromium picolinate (10ug/ml) + magnesium sulfate (12g/l) in drinking water, ( G8) led to a more reduction of blood glucose level comparing with diabetic rats.
The results were in a good agreement with those many authors Cefalu and Hu (2004) revealed that, low serum chromium concentrations can predict the development of type 2 diabetes mellitus . Furthermore, Albarracin et al., (2008) , they reported that,, supplementation of relatively high dosages of Cr picolinate (Cr Pic) decreased postprandial blood glucose. Alyssa et al., (2009) suggested that chromium enhances insulin internalization, insulin receptor number, and β-cell sensitivity.
However, Olatunji et al., (2008) have recently reported that dietary magnesium supplementation significantly improved the impaired glucose tolerance. 134.00 ± 1.0 Ba 160.0 ± 1.0 Bb 215.00 ± 1.00 B c G8 Each value is an average of five determinations ± s.d Means with different superscript capital letters (between groups at the same period "column") and small letters (within groups at different period "row ") are significantly different at p <0.05 G1, G2, G3 G4 …..etc as in Table (1).
Effect of feeding on different levels of Chromium picolinate and Magnesium sulfate on serum creatinine (mg/dl) in rats:
The change in serum creatinine level during experimental period is shown in Table ( 6) . At the beginning of the experimental period, serum creatinine recorded values of all groups were ranged between 1.0 to 2.3 mg/dl. And this range above of level of serum creatinine in normal value (0.6 to 1.4-mg/dl). But negative control had the lowest significant level of serum creatinine (1.0 mg/dl) and positive Control recorded the highest (2.4mg/dl). At the end of experimental period , from this table it was observed that diabetic control had the highest amount of creatinine contents (2.90 mg/dl),while the lowest creatinine contents from hypoglycemic diets G4 and G8 were 0.41and 0.55 mg/dl, respectively.
The results agree with (Alam, 2001) found that Streptozotocin injection caused a highly significant increase in serum uric acid, blood urea and creatinine relative to normal control. Serum uric acid was 6.0 mg/dl for diabetic control 1.6 mg/dl for normal control and urea was more than average values of the normal control 68.5 and 58.55 mg/dl, respectively. Each value is an average of five determinations ± s.d Means with different superscript capital letters (between groups at the same period "column") and small letters (within groups at different period "row ") are significantly different at p <0.05 G1, G2, G3 G4 …..etc as in Table (1).
Effect of feeding on different levels of Chromium picolinate and Magnesium sulfate on serum urea (mg/dl) in rats:
The results of urea, in plasma of normal control and diabetic rats, at the experimental period after feeding for 6 weeks are reported in Table (7) .The obtained results illustrated that at the end of experimental period for the control was 41.00mg/dl. The same table presented that urea contents of diabetic control showed a value of 63.00mg/dl in plasma, while the diabetic rats fed on different levels of Chromium picolinate and Magnesium sulfate had significantly lower serum urea compared to diabetic control fed on basal diet. Mean while, normal group fed on basal diet had a significantly lower mean value for urea. The obtained results are in agreed with those reported by Mita et al., (2004) . Table (7): Effect of feeding on different levels of Chromium picolinate and Magnesium sulfate on serum urea (mg/dl) in rats: serum urea (mg/dl) Dietary groups After 6 weeks After 3 weeks Initial time 41.00 ± 1.00Aa 40.33 ± 0.57Aa 42.00 ± 1.00Aa G1 63.00 ± 1.00Ec 62.00 ± 1.00Db 60.00 ±1.0CDa G2
43.33 ± 0.57Da 52.33 ± 0.57Cb 61.30 ± 0.10Dc G3 41.66 ± 0.57ABa 52.00 ± 1.00BCb 60.33 ±1.52CDc G4 42.40 ±0.10BCDa 51.33. ± 0.57BCb 61.00 ± 1.00Dc G5 42.5 ± 0.10BCDa 51.00 ± 1.00BCb 59.66 ± 0.57CDc G6 43.00 ± 1.00CDa 51.66 ± 0.57BCb 58.00 ± 1.00Bc G7 41.80 ± 0.1ABCa 50.70 ± 0.10Bb 59.20 ± 0.10BCc G8 Each value is an average of five determinations ± s.d Means with different superscript capital letters (between groups at the same period "column") and small letters ( within groups at different period "row ") are significantly different at p <0.05 G1, G2, G3 G4 …..etc as in Table (1). 
